Ledviclear Tablet

Get a Price/Quote

MOQ : 40 Bottles

Ledviclear Tablet Specification

Origin of Medicine
INDIA

Physical Form
Tablets

Recommended For
DOCTOR

Quantity
40 Boxes

Administration
Oral

Composition
Ledipasvir, Sofosbuvir

Strength
400 mg/90 mg

Manufactured By
Abbott Healthcare

Usage
Chronic HCV infection

Storage
Dry place

Ledviclear Tablet Trade Information

Minimum Order Quantity
40 Bottles

Delivery Time
1 Week

About Ledviclear Tablet

Ledviclear Tablet is an effective antiviral medication designed to combat chronic hepatitis C in both adults and children aged three years and older. By enhancing the bodys immune response, this medication not only aids in fighting the viral infection but also promotes liver recovery, potentially improving overall health outcomes. It's important for patients to follow their healthcare provider's guidance while using Ledviclear, as certain precautions and potential side effects may arise. Regular monitoring of liver function is recommended to ensure the treatment's efficacy and safety. Patients should be aware of possible interactions with other medications, making it crucial to discuss all current prescriptions with a healthcare professional. With its targeted approach, Ledviclear provides hope for those affected by this challenging condition, contributing to a better quality of life. Always consult a healthcare provider for personalized advice before starting any new treatment regimen.

Comprehensive Treatment for Chronic HCV Infection

Ledviclear Tablet is specifically formulated to target chronic Hepatitis C virus infection, utilizing the antiviral synergy of Ledipasvir and Sofosbuvir. Manufactured by Abbott Healthcare and available in India, this oral medication provides a convenient and effective option for managed HCV care under professional guidance.

Optimal Use and Storage Guidelines

For best results, Ledviclear Tablet should be taken orally as prescribed by a healthcare practitioner. It is important to store the medication in a dry place to preserve its efficacy. The bulk packaging (40 boxes) is suitable for distribution and use in clinical or hospital settings, as supplied by authorized distributors and wholesalers.

FAQ's of Ledviclear Tablet:

Q: How should Ledviclear Tablet be taken for chronic HCV infection?

A: Ledviclear Tablet is intended for oral administration and should be taken exactly as prescribed by your doctor. Follow your healthcare provider's dosage instructions carefully for optimal treatment outcomes.

Q: What is the main composition and benefit of using Ledviclear Tablet?

A: Ledviclear Tablet contains Ledipasvir (90 mg) and Sofosbuvir (400 mg). This combination is effective at inhibiting specific viral proteins, which helps to suppress and manage chronic HCV infections when administered under a doctor's supervision.

Q: When is it recommended to start treatment with Ledviclear Tablet?

A: Treatment with Ledviclear Tablet should begin after a confirmed diagnosis of chronic Hepatitis C and upon your doctor's recommendation. Do not start or stop the medication without consulting your healthcare provider.

Q: Where is Ledviclear Tablet manufactured and distributed from?

A: Ledviclear Tablet is manufactured by Abbott Healthcare in India and distributed domestically by authorized distributors, exporters, suppliers, traders, and wholesalers to ensure quality and regulatory compliance.

Q: What is the process for obtaining Ledviclear Tablet for clinical use?

A: Medical professionals can obtain Ledviclear Tablet through verified pharmaceutical distributors and wholesalers in India. Bulk packaging of 40 boxes is available to support hospital and clinical demands.

Q: What are the recommended storage conditions for Ledviclear Tablet?

A: Store Ledviclear Tablet in a dry place, away from excessive heat and moisture, to maintain its stability and effectiveness throughout its shelf life.

Q: What are the key benefits of Ledviclear Tablet for chronic HCV infection?

A: Ledviclear Tablet provides a potent, oral treatment option using the combined action of Ledipasvir and Sofosbuvir, improving viral clearance rates and helping patients achieve sustained virological response under medical supervision.

Tell us about your requirement